Workflow
David Medical(300314)
icon
Search documents
戴维医疗2025年中报简析:净利润同比增长9.57%,盈利能力上升
Zheng Quan Zhi Xing· 2025-08-22 23:20
本次财报公布的各项数据指标表现一般。其中,毛利率58.4%,同比增0.32%,净利率20.29%,同比增 15.92%,销售费用、管理费用、财务费用总计7315.8万元,三费占营收比29.12%,同比增1.58%,每股 净资产4.16元,同比增3.41%,每股经营性现金流-0.01元,同比减607.75%,每股收益0.18元,同比增 9.6% 据证券之星公开数据整理,近期戴维医疗(300314)发布2025年中报。截至本报告期末,公司营业总收 入2.51亿元,同比下降5.48%,归母净利润5097.67万元,同比上升9.57%。按单季度数据看,第二季度 营业总收入1.3亿元,同比上升17.74%,第二季度归母净利润2840.9万元,同比上升237.44%。本报告期 戴维医疗盈利能力上升,毛利率同比增幅0.32%,净利率同比增幅15.92%。 | 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 2.66亿 | 2.51亿 | -5.48% | | 归母净利润(元) | 4652.61万 | 5097.67万 | 9.5 ...
戴维医疗股价上涨5.38% 上半年净利润同比增长9.57%
Sou Hu Cai Jing· 2025-08-22 09:40
戴维医疗最新股价为15.47元,较前一交易日上涨5.38%。开盘价为15.76元,最高触及16.95元,最低下 探至15.22元,成交量为35.23万手,成交额达5.62亿元。 戴维医疗属于医疗器械板块,公司主营业务为儿产科保育设备及微创外科手术器械的研发、生产和销 售,同时布局急救手术ICU产品。2025年上半年,公司实现营业收入2.51亿元,同比下降5.48%;归属 于上市公司股东的净利润5097.67万元,同比增长9.57%。 风险提示:投资有风险,入市需谨慎。 来源:金融界 消息面上,戴维医疗披露2025年半年度报告,显示公司净利润同比增长9.57%。此外,公司第五届监事 会第十三次会议审议通过了多项议案。 资金流向方面,戴维医疗当日主力资金净流入1585.80万元,占流通市值的0.71%。近五日主力资金净流 入963.45万元,占流通市值的0.43%。 ...
戴维医疗收盘上涨5.38%,滚动市盈率72.19倍,总市值44.55亿元
Sou Hu Cai Jing· 2025-08-22 09:29
8月22日,戴维医疗今日收盘15.47元,上涨5.38%,滚动市盈率PE(当前股价与前四季度每股收益总和 的比值)达到72.19倍,总市值44.55亿元。 从行业市盈率排名来看,公司所处的医疗器械行业市盈率平均56.95倍,行业中值40.49倍,戴维医疗排 名第95位。 股东方面,截至2025年8月20日,戴维医疗股东户数22900户,较上次增加400户,户均持股市值35.28万 元,户均持股数量2.76万股。 宁波戴维医疗器械股份有限公司的主营业务是儿产科保育设备、微创外科手术器械等产品的研发、生产 和销售。公司的主要产品是儿产科保育设备、微创外科手术器械、急救手术ICU产品。截至报告期末, 公司及子公司累计拥有专利257项,其中发明专利70项、实用新型专利138项、外观设计专利49项,计算 机软件著作权9项。 最新一期业绩显示,2025年半年报,公司实现营业收入2.51亿元,同比-5.48%;净利润5097.67万元,同 比9.57%,销售毛利率58.40%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13戴维医疗72.1977.803.7244.55亿行业平均 56.9554.955.111 ...
戴维医疗(300314.SZ):2025年中报净利润为5097.67万元、较去年同期上涨9.57%
Xin Lang Cai Jing· 2025-08-22 02:53
2025年8月22日,戴维医疗(300314.SZ)发布2025年中报。 公司营业总收入为2.51亿元。归母净利润为5097.67万元,较去年同报告期归母净利润增加445.05万元, 同比较去年同期上涨9.57%。经营活动现金净流入为-398.39万元。 公司最新毛利率为58.40%,较上季度毛利率增加1.27个百分点,实现2个季度连续上涨,较去年同期毛 利率增加0.19个百分点。最新ROE为4.26%,较去年同期ROE增加0.24个百分点。 公司摊薄每股收益为0.18元,较去年同报告期摊薄每股收益增加0.02元,同比较去年同期上涨9.60%。 公司最新总资产周转率为0.18次。最新存货周转率为0.55次。 公司股东户数为1.94万户,前十大股东持股数量为1.97亿股,占总股本比例为68.44%,前十大股东持股 情况如下: | 序号 | 股东名称 | 持股比例 | | --- | --- | --- | | I | 陈再宏 | 45.81% | | 2 | 陈再慰 | 20.25% | | 3 | BARCLAYS BANK PLC | 0.42% | | 4 | 李则东 | 0.34% | | 5 | 中国 ...
戴维医疗:2025年半年度归属于上市公司股东的净利润同比增长9.57%
Zheng Quan Ri Bao· 2025-08-21 14:11
(文章来源:证券日报) 证券日报网讯 8月21日晚间,戴维医疗发布公告称,2025年半年度公司实现营业收入251,256,793.39 元,同比下降5.48%;归属于上市公司股东的净利润为50,976,694.29元,同比增长9.57%。 ...
戴维医疗:第五届监事会第十三次会议决议的公告
Zheng Quan Ri Bao· 2025-08-21 13:44
(文章来源:证券日报) 证券日报网讯 8月21日晚间,戴维医疗发布公告称,公司第五届监事会第十三次会议审议通过了《关于 公司2025年半年度报告全文及摘要的议案》等多项议案。 ...
戴维医疗(300314.SZ):上半年净利润5097.67万元 同比增长9.57%
Ge Long Hui A P P· 2025-08-21 13:27
格隆汇8月21日丨戴维医疗(300314.SZ)公布2025年半年度报告,上半年公司实现营业收入2.51亿元,同 比下降5.48%;归属于上市公司股东的净利润5097.67万元,同比增长9.57%;归属于上市公司股东的扣 除非经常性损益的净利润4071.09万元,同比下降7.95%;基本每股收益0.1770元。 ...
戴维医疗股价小幅回落 上半年净利润同比增长9.57%
Sou Hu Cai Jing· 2025-08-21 13:24
Group 1 - As of August 21, David Medical's stock price closed at 14.68 yuan, down 0.94% from the previous trading day, with a trading volume of 75,116 hands and a transaction amount of 111 million yuan [1] - David Medical focuses on the research, production, and sales of medical devices, with its main business covering three areas: obstetric and neonatal care equipment, minimally invasive surgical instruments, and emergency surgical ICU products. The medical device manufacturing sector accounted for 98.08% of the company's revenue in the 2024 annual report [1] - On August 21, the company announced that the fifth session of the thirteenth board of directors approved the proposal regarding the full text and summary of the 2025 semi-annual report. The semi-annual report showed that in the first half of 2025, the company achieved operating revenue of 251 million yuan, a year-on-year decrease of 5.48%, while the net profit attributable to shareholders of the listed company was 50.98 million yuan, a year-on-year increase of 9.57%. Notably, the second quarter performance was strong, with a year-on-year growth of 237.4% in net profit attributable to the parent [1] Group 2 - On August 21, David Medical saw a net inflow of main funds amounting to 2.7751 million yuan, with a cumulative net inflow of 2.1627 million yuan over the past five days [2]
戴维医疗:8月21日召开董事会会议
Sou Hu Cai Jing· 2025-08-21 12:43
Group 1 - The company, David Medical, announced that its 13th meeting of the 5th board of directors was held on August 21, 2025, to review the full and summary reports for the first half of 2025 [1] - For the year 2024, the revenue composition of David Medical was 98.08% from the medical device manufacturing sector and 1.92% from other businesses [1] - As of the report, David Medical's market capitalization is 4.2 billion yuan [2]
戴维医疗:2025年半年度净利润约5098万元,同比增加9.57%
Sou Hu Cai Jing· 2025-08-21 12:07
Group 1 - The core viewpoint of the article highlights that David Medical (SZ 300314) reported a decrease in revenue for the first half of 2025, while net profit increased [1] - The company's revenue for the first half of 2025 was approximately 251 million yuan, representing a year-on-year decrease of 5.48% [1] - The net profit attributable to shareholders was around 50.98 million yuan, showing a year-on-year increase of 9.57% [1] - Basic earnings per share were reported at 0.177 yuan, which is a 9.6% increase compared to the previous year [1] Group 2 - As of the report, David Medical's market capitalization stands at 4.2 billion yuan [2]